National Health Research Institutes, Taiwan clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 127 studies whose lead sponsor is National Health Research Institutes, Taiwan. 29 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 2, 2026.
Keep track of what changes. Save the National Health Research Institutes, Taiwan studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- Taiwan
- 111
Focus areas
Conditions National Health Research Institutes, Taiwan leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 127. Browse all 127 →
- NHRI Intelligent Voice Interactive Platform for High-Quality Community Living Among Older AdultsRecruitingNCT07855874Not applicable
- The Validation of ICBT Clinical Trial: Disease Stress Adjustment in Breast Cancer PatientsNot yet recruitingNCT07835698Not applicable
- Liposomal Irinotecan Plus Cisplatin in Patients With Advanced or Metastatic Solid MalignanciesNot yet recruitingNCT07782346Phase 1
- Assistive Device Rental/Purchase, LTC Service Use, and Caregiver Burden in TaiwanNot yet recruitingNCT07782047
- Quantitative Monitoring of Disability Care Quality for Long-Term Care Facilities 2RecruitingNCT07579832Not applicable
- Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-Therapy DeviceNot yet recruitingNCT07764107Not applicable
- The Registry Study of Genetic Alterations of Oropharyngeal Cancer in TaiwanRecruitingNCT05522881
- Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY)RecruitingNCT06981637Phase 2
- Social Prescribing Intervention for Health Promotion in Community-Dwelling Older AdultsRecruitingNCT07540117Not applicable
- Adult Disease Risk Prediction Using Wearables, Hearing, and Health DataRecruitingNCT07541547
- Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .RecruitingNCT05927857Phase 1/2
- Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine TumorsRecruitingNCT05048901Phase 1/2
- The Registry of Genetic Alterations of Taiwan Ovarian CancerRecruitingNCT06127446
- The Research Plan of Taiwan Precision MedicineRecruitingNCT04849481
- Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)RecruitingNCT06271200Not applicable
- Plant-based Diets and Healthy AgingRecruitingNCT07151365
- Precision Vibration Therapy for Neuromuscular and Functional Improvement in Older Adults and Stroke SurvivorsRecruitingNCT07351877Not applicable
- Chronic Wounds and Blood Circulation DetectionRecruitingNCT07330635Not applicable
- Effects of Mindfulness or Brain Stimulation Intervention for Late-life Adults in Taiwan Urban and Rural AreasRecruitingNCT07186023Not applicable
- Internet-Based Cognitive Behavioral Therapy With Treatment as Usual for Generalized Anxiety Disorder and Major Depressive Disorder in Taiwan (ICBT-TW)Not yet recruitingNCT07177365Not applicable
- A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse GliomaRecruitingNCT05622409
- Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination TherapyNot yet recruitingNCT07151326Phase 2
- Taiwanese Anaplastic Thyroid Cancer RegistryNot yet recruitingNCT07138261
- Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NETEnrolling by invitationNCT05385861Phase 1/2
- The Registry Study of Genetic Alterations of Melanoma in TaiwanRecruitingNCT06952400
- Peri-operative SLOG for Localized Pancreatic CancerRecruitingNCT05048524Phase 2
- Genomics and Prognosis in GI CancersRecruitingNCT05767697
- Neoantigen Derived DCs as Cancer TreatmentRecruitingNCT05767684Phase 1
- A Phase I/II Study of Diffuse Large B-cell LymphomaNot yet recruitingNCT04856137Phase 1/2
- Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma.CompletedNCT04688151Phase 1
- Observational Registry Data on GIST PatientsCompletedNCT03602092
- The Registry of Genetic Alterations of Taiwan Biliary Tract CancerActive, not recruitingNCT05036486
- Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based TreatmentActive, not recruitingNCT05170438Phase 2
- Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor PatientsActive, not recruitingNCT04821895
- A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic CancerActive, not recruitingNCT05026905Phase 2
- Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer.WithdrawnNCT07369791Phase 2
- Atezolizumab Plus Bevacizumab With HCC and HBV InfectionActive, not recruitingNCT04180072Not applicable
- Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract CancerCompletedNCT03406299Phase 2
- SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic CancerCompletedNCT03443492Phase 2
- The Effects of a Meditation Intervention on the Psychological Burden of Long-Term Care Professionals and Family CaregiversCompletedNCT07188454Not applicable
- A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNATerminatedNCT02363400Phase 3
- Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral EtiologiesActive, not recruitingNCT05613621
- Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission PatientsCompletedNCT01744587Not applicable
- NGS as the First-line Treatment in Advanced Biliary Tract CancerCompletedNCT04172402Phase 2
- The Registry of Genetic Expression of Taiwan Urologic CancerActive, not recruitingNCT05725304
- A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients (TOPICS-THYROID)Active, not recruitingNCT05541380
- The Registry Study of Genetic Alterations of Esophageal Cancer in TaiwanActive, not recruitingNCT04996095
- Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell LymphomasTerminatedNCT05105412Phase 1/2
- Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)CompletedNCT03510871Phase 2
- BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study)CompletedNCT04839471Phase 2